In Vitro Generation of Human Dendritic Cell Subsets from CD34+ Cord Blood Progenitors.

CD34 Conventional dendritic cells Cord blood Dendritic cells Hematopoietic stem cells In vitro differentiation Mesenchymal stromal cells Plasmacytoid dendritic cell

Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2023
Historique:
entrez: 11 3 2023
pubmed: 12 3 2023
medline: 15 3 2023
Statut: ppublish

Résumé

Dendritic cells (DCs) are professional antigen-presenting cells controlling the activation of T cells and thus regulating adaptive immune response against pathogens or tumors. Modeling human DC differentiation and function is crucial for our understanding of immune response and the development of new therapies. Considering DC rarity in human blood, in vitro systems allowing their faithful generation are needed. This chapter will describe a DC differentiation method based on the co-culture of CD34

Identifiants

pubmed: 36905513
doi: 10.1007/978-1-0716-2938-3_9
doi:

Substances chimiques

Antigens, CD34 0
Cell Adhesion Molecules 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-132

Informations de copyright

© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Guermonprez P, Gerber-Ferder Y, Vaivode K, Bourdely P, Helft J (2019) Origin and development of classical dendritic cells. Int Rev Cell Mol Biol. Elsevier 349:1–54
doi: 10.1016/bs.ircmb.2019.08.002
Bachem A et al (2010) Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 207:1273–1281
doi: 10.1084/jem.20100348 pubmed: 20479115 pmcid: 2882837
Bourdely P et al (2020) Transcriptional and functional analysis of CD1c+ human dendritic cells identifies a CD163+ subset priming CD8+CD103+ T cells. Immunity 53:335–352.e8
doi: 10.1016/j.immuni.2020.06.002 pubmed: 32610077 pmcid: 7445430
Nakamizo S et al (2021) Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis. J Exp Med 218:e20202345
doi: 10.1084/jem.20202345 pubmed: 34279540 pmcid: 8292131
See P et al (2017) Mapping the human DC lineage through the integration of high-dimensional techniques. Science 356:eaag3009
doi: 10.1126/science.aag3009 pubmed: 28473638 pmcid: 7611082
Villani A-C et al (2017) Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356:eaah4573
doi: 10.1126/science.aah4573 pubmed: 28428369 pmcid: 5775029
Goudot C et al (2017) Aryl hydrocarbon receptor controls monocyte differentiation into dendritic cells versus macrophages. Immunity 47:582–596.e6
doi: 10.1016/j.immuni.2017.08.016 pubmed: 28930664
Segura E et al (2013) Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38:336–348
doi: 10.1016/j.immuni.2012.10.018 pubmed: 23352235
Anselmi G et al (2020) Engineered niches support the development of human dendritic cells in humanized mice. Nat Commun 11:2054
doi: 10.1038/s41467-020-15937-y pubmed: 32345968 pmcid: 7189247
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
doi: 10.1038/32588 pubmed: 9521319
Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109–1118
doi: 10.1084/jem.179.4.1109 pubmed: 8145033
Balan S et al (2018) Large-scale human dendritic cell differentiation revealing notch-dependent lineage bifurcation and heterogeneity. Cell Rep 24:1902–1915.e6
doi: 10.1016/j.celrep.2018.07.033 pubmed: 30110645 pmcid: 6113934
Blom B, Ho S, Antonenko S, Liu Y-J (2000) Generation of interferon α–producing predendritic cell (Pre-Dc)2 from human Cd34+ hematopoietic stem cells. J Exp Med 192:1785–1796
doi: 10.1084/jem.192.12.1785 pubmed: 11120775 pmcid: 2213503
Breton G et al (2015) Circulating precursors of human CD1c+ and CD141+ dendritic cells. J Exp Med 212:401–413
doi: 10.1084/jem.20141441 pubmed: 25687281 pmcid: 4354370
Dontje W et al (2006) Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B. Blood 107:2446–2452
doi: 10.1182/blood-2005-05-2090 pubmed: 16317090
Helft J et al (2017) Dendritic cell lineage potential in human early hematopoietic progenitors. Cell Rep 20:529–537
doi: 10.1016/j.celrep.2017.06.075 pubmed: 28723558 pmcid: 5529209
Kirkling ME et al (2018) Notch signaling facilitates in vitro generation of cross-presenting classical dendritic cells. Cell Rep 23:3658–3672.e6
doi: 10.1016/j.celrep.2018.05.068 pubmed: 29925006 pmcid: 6063084
Lee J et al (2015) Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med 212:385–399
doi: 10.1084/jem.20141442 pubmed: 25687283 pmcid: 4354373
Poulin LF et al (2010) Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells. J Exp Med 207:1261–1271
doi: 10.1084/jem.20092618 pubmed: 20479117 pmcid: 2882845
Proietto AI, Mittag D, Roberts AW, Sprigg N, Wu L (2012) The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34+ stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin. Cell Mol Immunol 9:446–454
doi: 10.1038/cmi.2012.48 pubmed: 23085949 pmcid: 4002222
Schotte R, Nagasawa M, Weijer K, Spits H, Blom B (2004) The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J Exp Med 200:1503–1509
doi: 10.1084/jem.20041231 pubmed: 15583020 pmcid: 2211952
Balan S et al (2014) Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol 193:1622–1635
doi: 10.4049/jimmunol.1401243 pubmed: 25009205 pmcid: 4120898
Thordardottir S et al (2014) The aryl hydrocarbon receptor antagonist StemRegenin 1 promotes human plasmacytoid and myeloid dendritic cell development from CD34+ hematopoietic progenitor cells. Stem Cells Dev 23:955–967
doi: 10.1089/scd.2013.0521 pubmed: 24325394
Chen W et al (2004) Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 103:2547–2553
doi: 10.1182/blood-2003-09-3058 pubmed: 14670916
Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH (2000) Id2 and Id3 inhibit development of Cd34+ stem cells into predendritic cell (Pre-Dc)2 but not into Pre-Dc1: evidence for a lymphoid origin of Pre-Dc2. J Exp Med 192:1775–1784
doi: 10.1084/jem.192.12.1775 pubmed: 11120774 pmcid: 2213506
Sander J et al (2017) Cellular differentiation of human monocytes is regulated by time-dependent interleukin-4 signaling and the transcriptional regulator NCOR2. Immunity 47:1051–1066.e12
doi: 10.1016/j.immuni.2017.11.024 pubmed: 29262348 pmcid: 5772172
Breton G et al (2016) Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs. J Exp Med 213:2861–2870
doi: 10.1084/jem.20161135 pubmed: 27864467 pmcid: 5154947
Itoh K et al (1989) Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol 17:145–153
pubmed: 2783573

Auteurs

Pierre Bourdely (P)

Institut Cochin, INSERM U1016, CNRS UMR8104, Université de Paris Cité, Paris, France. pierre.bourdely@inserm.fr.

Roberto Savoldelli (R)

King's College London, Centre for Inflammation Biology and Cancer Immunology, London, UK.
Université de Paris, INSERM U1149, CNRS erl8252, Centre for Inflammation Research, Université de Paris Cité, Paris, France.

Mathias Vetillard (M)

Université de Paris, INSERM U1149, CNRS erl8252, Centre for Inflammation Research, Université de Paris Cité, Paris, France.

Giorgio Anselmi (G)

King's College London, Centre for Inflammation Biology and Cancer Immunology, London, UK.
Oxford University, Radcliffe Department of Medicine, Oxford, UK.

Julie Helft (J)

Institut Cochin, INSERM U1016, CNRS UMR8104, Université de Paris Cité, Paris, France.

Pierre Guermonprez (P)

Université de Paris, INSERM U1149, CNRS erl8252, Centre for Inflammation Research, Université de Paris Cité, Paris, France. pierre.guermonprez@cnrs.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH